Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL +5.63%31 PS Ratio is 0.78 as of Aug. 06, 2026, which is 64% below its 10-year median of 2.17. GuruFocus rates NZSE:PHL with a GF Score™ of 31/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Promisia Healthcare ranks better than 70.62% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Promisia Healthcare's share price is NZ$0.75.
Promisia Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.96. Hence, Promisia Healthcare's PS Ratio for today is 0.78.
Warning Sign:
Promisia Healthcare Ltd stock PS Ratio (=1.1) is close to 3-year high of 1.12.
The historical rank and industry rank for Promisia Healthcare's PS Ratio or its related term are showing as below:
NZSE:PHL'
s PS Ratio Range Over the Past 10 Years
Min: 0.01 Med: 2.17 Max: 48.16
Current: 0.79
During the past 13 years, Promisia Healthcare's highest PS Ratio was 48.16. The lowest was 0.01. And the median was 2.17.
NZSE:PHL's PS Ratio is ranked better than 70.62% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs NZSE:PHL: 0.79
Promisia Healthcare Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Promisia Healthcare was 23.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 71.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 22.50% per year.
During the past 13 years, Promisia Healthcare's highest 3-Year average Revenue per Share Growth Rate was 1010.90% per year. The lowest was -67.10% per year. And the median was 10.60% per year.
Promisia Healthcare (NZSE:PHL) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Promisia Healthcare PS Ratio Related Terms
Promisia Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Promisia Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Promisia Healthcare's Share Price of today is NZ$0.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Promisia Healthcare (NZSE:PHL) has a PS Ratio of 0.78 as of Aug. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Promisia Healthcare and its competitors. This is 64% below median its historical median of 2.17. Over the past decade, Promisia Healthcare's PS Ratio has ranged from 0.01 to 48.16. According to the industry distribution chart, Promisia Healthcare ranks #193 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 29.4%.
Is Promisia Healthcare's PS Ratio too high?
Promisia Healthcare's current PS Ratio of 0.78 is 64% below median its 10-year median of 2.17. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 48.16. The Healthcare Providers & Services industry median PS Ratio is 1.52. Promisia Healthcare's value of 0.78 is 48.7% below this industry median. Based on the distribution chart, Promisia Healthcare ranks #193 out of 657 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Promisia Healthcare has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #193 out of 657 companies for PS Ratio. This puts Promisia Healthcare in the upper half of its industry. The industry median PS Ratio is 1.52. Promisia Healthcare's value of 0.78 is 48.7% below this benchmark. Historically, Promisia Healthcare's own PS Ratio has ranged from 0.01 to 48.16 over the past decade. While the company's 10-year median is 2.17 vs. the industry median of 1.52, Promisia Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisia Healthcare's current PS Ratio of 0.78 is 48.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current PS Ratio is 0.78, which is 64% below median its own 10-year median of 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.75 — trading 78.6% above its estimated fair value. The current PS Ratio is 0.78, which is 64% below median its 10-year median of 2.17 and 48.7% below the Healthcare Providers & Services industry median of 1.52. Promisia Healthcare's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current PS Ratio is 0.78 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.75 is trading 78.6% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
PS Ratio: 0.78 (64% below median its 10-year median of 2.17)
GF Value™: NZ$0.42 vs. price of NZ$0.75 (78.6% above fair value)
Industry Position: 48.7% below the Healthcare Providers & Services median (#193 of 657)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
31GF Score
Get the complete analysis for NZSE:PHL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
